S. Tamaki

β-blockers may be detrimental in frail patients with heart failure with preserved ejection fraction.

S. Hikoso, Y. Yasumura, H. Kurakami, 2023, Clinical research in cardiology : official journal of the German Cardiac Society.

The WATCH-DM risk score estimates clinical outcomes in type 2 diabetic patients with heart failure with preserved ejection fraction

M. Nishino, Hiroyasu Kato, R. Shutta, 2024, Scientific reports.

Low‐density lipoprotein cholesterol, erythrocyte, and platelet in heart failure with preserved ejection fraction

M. Nishino, Y. Egami, S. Hikoso, 2024, ESC heart failure.

Clinical trajectories and outcomes of patients with heart failure with preserved ejection fraction with normal or indeterminate diastolic function

M. Nishino, Hiroyasu Kato, R. Shutta, 2022, Clinical Research in Cardiology.